Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Mazdutide for Pre-hepatectomy Prehabilitation in Living Liver Donors With MASLD
NCT07718126Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 4 trial of mazdutide in metabolic dysfunction-associated steatohepatitis (MASH), hepatic steatosis, sponsored by West China Hospital of Sichuan University. Started Sep 2026; status: recruiting.
02
Drugs
mazdutide
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)hepatic steatosis
Beyond the preview
Go deeper on NCT07718126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07718126.